Immunogenicity and safety of Institut Pasteur du Cambodge (IPC) and updated Thai Red Cross (UTRC) intradermal rabies vaccine regimens among healthy adults in India: A phase 4, open label, equivalence randomised controlled trial

Jeromie Wesley Vivian Thangaraj, Padinjaremattathil Thankappan Ullas, Balaji Dagadu More, Lokesh Shanmugam, Saravanakumar Velusamy, Dinesh Gopal, Subashri Ramamoorthy, Kanagasabai Kaliaperumal, Mugunthan N. M, Sandhya Arunachalam, Ramaprabha Ramachandran, Gopinath Ramakrishnan, Suresh Arunachalam, Vijay Vidhyakar J. M, Ganeshnee Anthuvan Valli, Siddharth Pugalendhi, Sabarinathan Ramasamy, Karunakaran T, Mohamed Hanifah, Sam Joy, Anoop Velayudhan, Suganya Egambaram, Ala Saritha, Manju Rahi, Simmi Tiwari, Vijay Parashramji Bondre, Manoj V. Murhekar, the Rabies Vaccine Immunogenicity Trial (RVIT) study group

DOI: 10.1371/journal.pmed.1005079

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.